Erst- und Letztautorenschaften


  1. Stent-induced flow disturbances in the ipsilateral external carotid artery following internal carotid artery stenting: A temporary cause of jaw claudication. (Wien Klin Wochenschr 2017;129:487-490)
  2. Vascular puncture site complication - diagnosis, therapy and prognosis. (Vasa 2016;45:461-469)
  3. Percutaneous instillation of physiological saline solution for the treatment of femoral pseudoaneurysms. (Wien Klin Wochenschr 2016;128:421-425)
  4. Perspectives of mobile communication in the management of diabetics. (Wien Med Wochenschr 2011;161:359-360)
  5. Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosis. (Eur J Clin Invest 2010;41:365-341)
  6. D-Dimer testing After Percutaneous Transluminal Procedures.?Make Pseudoaneurysms a difference? (J Vasc Surg 2010;52:383-387)
  7. Correlation of Infrared Thermography and Skin Perfusion in Raynaud Patients and in Healthy controls. (Microvasc Res 2010;80:54-57)
  8. Access site management after peripheral percutaneous transluminal procedures: Neptune PAD ® compared with conventional manual compression. (Radiology. 2008;249:1058-1063)
  9. Improvement of neurocognitive Funtions after protected Carotid Artery Stenting. (Cath Cardiovasc Int 2008;71:114-119)
  10. Is there Improvement of “vascular depression” after carotid artery stenting? (Radiology 2006;240:508-514)
  11. Prediction of iatrogenic Pseudoaneurysms after percuatneous endovascular procedures. (Radiology 2006;240:597-602)
  12. Arterial puncture site management after percutaneous transluminal procedures using a hemostatic wound dressing (Clo-Sur P.A.D) vs. conventional manual compression – a randomized controlled trial. (J Endovasc Ther 2006;13:21-31)
  13. Hautnekrose nach Kanülierung der A. radialis zum invasivem Monitoring. (Z Gefaessmed 2006;3:26-27)
  14. Perkutane Thrombininjektion bei iatrogenem Pseudoaneurysma der Arteria femoralis communis. (Z Gefaessmed 2005;2:18-19)
  15. Twenty-eight Year Old HIV Positive Male Patient with Ergotism. Interaction of Ergot-alkaloids and Protease-inhibitors. (Eur J Vasc Endovasc Surg 2005;29:556-557)
  16. Cognitive functions in patients with cerebrovascular disease: potential impact of revascularization. (Future Cardiol 2005;1:759-766)
  17. Iatrogene Pseudoaneurysmen nach perkutanen Gefäßeingriffen. (Z Gefaessmed 2005;2:9-11)
  18. E-Selectine Genotype and Plasma Levels predicting Restenosis after femoropopliteal Angioplasty. (Thromb Haemost 2004,91:171-179)
  19. Serum creatinine predicts mortality in patients with peripheral artery disease – Influence of diabetes and hypertension. (Atherosclerosis 2004;175:361-367)
  20. Effects of Intravenous Prostaglandin E1 on Arterial compliance: A Randomized Controlled Trial. (VASA 2004;33:131-136)
  21. Hypotension and bradycardia after elective carotid stenting: frequency and risk factors. (J Endovasc Ther 2003;10:851-859)
  22. Plasminogen Activator Inhibitor-1 and Outcome after Femoropopliteal Percutaneous Angioplasty: Analysis of Genotype and Serum levels. (Thromb Haemost 2003;90:717-723)
  23. Outcome of conservative medical treatment of patients with infrarenal abdominal aortic aneurysms. (Wien Klin Wochschr 2002;114:898-903)
  24. Clinical outcome and prognostic factors for ischemic ulcers treated with PTA in lower limbs. (Eur J Vasc Endovasc 2002;24:176-181)    


  1. Combined effects of inflammatory status and carotid atherosclerosis: A 12-year follow-up study. (Stroke 2016;47:2952-2958)
  2. The impact of selecting on mortality in stable carotid atherosclersis. (Thromb Haemost 2015;114:632-638)
  3. Relationship of age and body mass index to skin temperature and skin perfusion in primary Raynaud`s phenomenon. (Arthritis Rheumatoid 2015;67: 238-242)
  4. Renal Function and Long-term Mortality in Patients with asymptomatic Carotis Atherosclerosis (Thromb Haemost 2012;107:150-157)
  5. Incidence of Thrombotic and Bleeding Complications during Cardia Catheterization in Children: Comparison of High-dose versus Low-dose Heparin Protocols (J Thromb Haemost 2011;9:2353-2560)
  6. The prognostic impact of soluble apoptosis-stimulating fragment on mortality in patients with carotid atherosclerosis. (Stroke 2011;42:2465-70)
  7. The impact of dental disease on mortality in patients with asymptomatic carotid atherosclerosis. (Swiss Med Wkly 2011;141)
  8. Beta 2 microglobulin and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. (Stroke 2011;42:1826-33)
  9. Evidence of carotid atherosclerosis in orthopantomograms and the risk for future cardiovascular events. (Vasa 2010;39:298-304)
  10. Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis. (Stroke 2010;41:674-679)
  11. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. (Catheter Cardiovasc Interv 2009;74:1090-5)
  12. Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease. (Eur J Clin Invest 2009;39:784-792)
  13. Inflammation and adverse cardiovascular outcome in patients with renal artery stenosis and peripheral artery disease. (Atherosclerosis 2009;205:314-318)
  14. Increasing carotid plaque echolucency is predictive of cardiovascular events in high-risk patients. (Radiology 2008;248:1050-1055)
  15. Complications After Peripheral Vascular Interventions in Octogenarians (JEVT 2008;15:383-389)
  16. Decreasing Incidence of Critical Limb Ischemia After Intra-aortic Balloon Pump Counterpulsation. (Angiology 2009;60:235-41)
  17. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. (Radiology 2008;248:297-302)
  18. De Novo Superficial Femoropopliteal Artery Lesions: Peripheral Cutting Balloon Angioplasty and Restenosis Rates--Randomized Controlled Trial (Radiology 2008;247:267-272)
  19. Progression of Carotid Stenosis Detected by Duplex Ultrasonography Predicts Adverse Outcomes in Cardiovascular High-Risk Patients. (Stroke 2007;38:2887-2894)
  20. Duplex Sonography Versus Angiography for Assessment of Femoropopliteal Arterial Disease in A "real-world" Setting. (JEVT 2007;14:452-9)
  21. Quality of Life After Balloon Angioplasty Versus Stent Implantation in the Superficial Femoral Artery: Findings from a Randomized Controlled Trial. (JEVT 2007;14:431-437)
  22. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. (Circulation 2007;115:2745-2749)
  23. C-Reactive Protein Predicts Future Cardiovascular Events in Patients With Carotid Stenosis (Stroke 2007;38:1263-1268)
  24. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease (EJCI 2007;37:180-186)
  25. Complement Component C5a Predicts Restenosis After Superficial Femoral Artery Balloon Angioplasty (JEVT 2007;14:62-69)
  26. Asymmetric Dimethylarginine Predicts Major Adverse Cardiovascular Events in Patients With Advanced Peripheral Artery Disease. (ATVB 2006;26:2536-2540)
  27. Dental and Periodontal Status and Risk for Progression of Carotid Atherosclerosis. The Inflammation and Carotid Artery Risk for Atherosclerosis Study Dental Substudy. (Stroke 2006;37:2271-2276)
  28. Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. (JACC 2006;47:2212-2218)
  29. Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery (New Engl J Med 2006;354:1879-1888)
  30. Outcome after endovascular treatment of deep femoral artery stenosis: results in a consecutive patient series and systematic review of the literature. (J Endovasc Ther 2006;13:221-8)
  31. Long-Segment SFA Stenting-The Dark Sides: In-Stent Restenosis, Clinical Deterioration, and Stent Fractures. (J Endovasc Ther 2005;12:676-684)
  32. Haem oxygenase-1 genotype and cardiovascular adverse events in patients with peripheral artery disease. (Eur J Clin Invest 2005;35 :731-737)
  33. Procedure-related complications and early neurological adverse events of unprotected and protected carotid stenting: temporal trends in a consecutive patient series. (J Endovasc Ther 2005;12:538-547)
  34. Association of a Functional Polymorphism in the Clopidogrel Target Receptor Gene, P2Y12, and the Risk for Ischemic Cerebrovascular Events in Patients With Peripheral Artery Disease. (Stroke 2005;36:1394-1399)
  35. Prognostic Impact of Fibrinogen in Carotid Atherosclerosis. Nonspecific Indicator of Inflammation or Independent Predictor of Disease Progression? (Stroke 2005;36:1400-1404)
  36. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. (J Vasc Surg 2005;41 :610-617)
  37. Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS). (Circulation 2005;111:2203-2209)
  38. Neurological outcome of conservative versus endovascular treatment of patients with asymptomatic high-grade carotid artery stenosis: a propensity score-adjusted analysis. (J Endovasc Ther 2005;12:145-155)
  39. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries (J Endovasc Ther 2005;12:6-12)
  40. Insulin, C-peptide, and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients (J Vasc Interv Radiol 2005;16:31-5)
  41. High plasma heparin cofactor II activity protects from restenosis after femoropopliteal stenting (Thromb Haemost 2004;92:1108-13)
  42. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis (Radiology 2004;232:516-21)
  43. Quantification of internal carotid artery stenosis with duplex US: comparative analysis of different flow velocity criteria (Radiology 2004;232:431-9)
  44. Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions (Radiology 2004;231:831-8)
  45. Interleukin-6 promoter genotype and restenosis after femoropopliteal balloon angioplasty: initial observations (Radiology 2004;231:839-44)
  46. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease (Eur Heart J 2004;25:742-8.)
  47. Long-term follow-up after percutaneous transluminal angioplasty of the distal abdominal aorta (Vasa 2004;33:49-51)
  48. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor (J Am Coll Cardiol 2004;43:950-7)
  49. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors (Thromb Haemost 2004;91:610-8)
  50. Contralateral High-Grade Carotid Artery Stenosis or Occlusion Is Not Associated with Increased Risk for Poor Neurologic Outcome after Elective Carotid Stent Placement (Radiology 2004;230:70-76)
  51. Endovascular Brachytherapy: Effect on Avute Inflammatory Response after percutaneous femoropopliteal arterial interventions (Radiology 2004;230:556-560)
  52. Low Serum Magnesiun predicts neurological events in patients with advanced atherosclerosis (Stroke 2004;35:22-27)
  53. Joint effects of C-reactive protein and glycated hemoglobin in predicting future events of patients with advanced atherosclerosis (Circulation 2003;108:2323-2328)
  54. Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty (Thromb Haemost 2003;90:491-500)
  55. Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up (J Endovasc Ther 2003;10:288-294)
  56. Restenosis after femoropopliteal PTA and elektive stent implantation: predictive value of monocyte counts (J Endovasc Ther 2003;10:557-565)
  57. Endovascular revascularization below the knee: 6 months results and predictive value of C-reactive protein level (Radiology 2003;227;419-425)
  58. Acute-phase response after stent implantation in the carotid artery: association with 6 month in-stent restenosis (Radiology 2003;227:516-521)
  59. Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis (Thromb Res 2002;108:279-285)
  60. Vascular Inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis (Radiology 2002;225:21-26)
  61. Heme oxygenase-1 genotype is a vascular anti-inflammatory factor following balloon angioplasty (J Endovasc Ther 2002;9:385-94)
  62. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm (Thromb Res 2002;106:131-136)
  63. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries (Radiology 2002;224:529-35)
  64. Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries (Thromb Haemost 2002;87:959-65)
  65. Outcome of conservative versus interventional treatment of subclavian artery stenosis (J Endovasc Ther 2002;9:139-46)
  66. Balloon angioplasty and stent implantation induce a vascular inflammatory reaction (J Endovasc Ther 2002;9:59-66)
  67. Reduction in renal function after renal arteriography and after renal artery angioplasty (Eur J Vasc Endovasc 2002,24:156-160)
  68. Renal artery PTA and Stent implantation: Immediate and late clinical and morphological outcome (Wien Klin Wochenschr 2002;114:21-27)
  69. Carotid Artery Stenting in older patients: is age a risk factor for poor outcome? (J Endovasc Ther 2002;9:559-565)
  70. Relation of small artery compiance and Lipoprotein (a) in patients with atherosclerosis (Am J Hypertens 2002;15:980-985)
  71. Anti chlamydia antibodies in patients with thoracic and abdominal aortic aneurysms (Wien Klin Wochenschr 2002;23/24:972-977)
  72. Predicting renal failure after balloon angioplasty in high-risk patients (J Endovasc Ther 2001;8:609-14)
  73. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation (J Endovasc Ther 2001;8:477-83)
  74. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty (J Endovasc Ther 2001;8:433-40)